Cargando…
Current Use of Baricitinib in COVID-19 Treatment and Its Future: An Updated Literature Review
The levels of infectivity and mortality that ensued due to the coronavirus disease 2019 (COVID-19) pandemic caused an apparent global outcry. The health system, burdened by increasing deaths and hospitalizations, sought more effective treatment. This necessitated scientists and researchers to utiliz...
Autores principales: | Dupuis, Derma, Fritz, Kasinda, Ike, Emeka, Arogundade, Oyinkansola, Adewara, Enoch O, Monday, Esther O, Ayinde, Bolaji O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526681/ https://www.ncbi.nlm.nih.gov/pubmed/36199657 http://dx.doi.org/10.7759/cureus.28680 |
Ejemplares similares
-
Are There Any Ethnic Differences in the Response to Baricitinib for the Treatment of Rheumatoid Arthritis?
por: Zahir Hussain, Wajith Hussain, et al.
Publicado: (2021) -
Use of Baricitinib in Combination With Remdesivir and Steroid in COVID-19 Treatment: A Multicenter Retrospective Study
por: So, Jessica M, et al.
Publicado: (2021) -
Current Status of Baricitinib as a Repurposed Therapy for COVID-19
por: Saber-Ayad, Maha, et al.
Publicado: (2021) -
Immune Thrombocytopenia: A Rare Adverse Event of Vancomycin Therapy
por: Obi, Emeka S, et al.
Publicado: (2023) -
Neuropsychiatric Systemic Lupus Erythematosus: A 2021 Update on Diagnosis, Management, and Current Challenges
por: Sarwar, Sobia, et al.
Publicado: (2021)